Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Machine-Learning-Based Prediction of Treatment Outcomes Using MR Imaging-Derived Quantitative Tumor Information in Patients with Sinonasal Squamous Cell Carcinomas: A Preliminary Study.

Fujima N, Shimizu Y, Yoshida D, Kano S, Mizumachi T, Homma A, Yasuda K, Onimaru R, Sakai O, Kudo K, Shirato H.

Cancers (Basel). 2019 Jun 10;11(6). pii: E800. doi: 10.3390/cancers11060800.

2.

[A Nutritional Supplement with a High Blend Ratio of ω-3 Fatty Acids(Prosure®) Reduces Severe Oral Mucositis and Body Weight Loss for Head and Neck Cancer Patients Treated with Chemoradiotherapy].

Mizumachi T, Kano S, Homma A, Akazawa M, Hasegawa C, Shiroishi Y, Okamoto C, Kumagai S, Nishimura M, Takasaki H, Takeda H, Yasuda K, Minatogawa H, Dekura Y, Onimaru R, Shirato H, Fukuda S.

Gan To Kagaku Ryoho. 2019 Apr;46(4):685-689. Japanese.

PMID:
31164507
3.

Clinical experience of craniospinal intensity-modulated spot-scanning proton therapy using large fields for central nervous system medulloblastomas and germ cell tumors in children, adolescents, and young adults.

Hashimoto T, Shimizu S, Takao S, Terasaka S, Iguchi A, Kobayashi H, Mori T, Yoshimura T, Matsuo Y, Tamura M, Matsuura T, Ito YM, Onimaru R, Shirato H.

J Radiat Res. 2019 Jul 1;60(4):527-537. doi: 10.1093/jrr/rrz022.

PMID:
31111946
4.

Long-Term Evaluation of Combination Treatment of Single Agent HD-MTX Chemotherapy up to Three Cycles and Moderate Dose Whole Brain Irradiation for Primary CNS Lymphoma.

Kobayashi H, Yamaguchi S, Motegi H, Kaneko S, Endou S, Onimaru R, Terasaka S, Houkin K.

J Chemother. 2019 Feb;31(1):35-41. doi: 10.1080/1120009X.2018.1546984.

PMID:
30773132
5.

Semi-quantitative analysis of pre-treatment morphological and intratumoral characteristics using 18F-fluorodeoxyglucose positron-emission tomography as predictors of treatment outcome in nasal and paranasal squamous cell carcinoma.

Fujima N, Hirata K, Shiga T, Yasuda K, Onimaru R, Tsuchiya K, Kano S, Mizumachi T, Homma A, Kudo K, Shirato H.

Quant Imaging Med Surg. 2018 Sep;8(8):788-795. doi: 10.21037/qims.2018.09.09.

6.

Case Series of 23 Patients Who Developed Fatal Radiation Pneumonitis After Stereotactic Body Radiotherapy for Lung Cancer.

Onishi H, Marino K, Yamashita H, Terahara A, Onimaru R, Kokubo M, Shioyama Y, Kozuka T, Matsuo Y, Aruga T, Hiraoka M.

Technol Cancer Res Treat. 2018 Jan 1;17:1533033818801323. doi: 10.1177/1533033818801323.

7.

Final report of survival and late toxicities in the Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702).

Onimaru R, Onishi H, Ogawa G, Hiraoka M, Ishikura S, Karasawa K, Matsuo Y, Kokubo M, Shioyama Y, Matsushita H, Ito Y, Shirato H.

Jpn J Clin Oncol. 2018 Dec 1;48(12):1076-1082. doi: 10.1093/jjco/hyy141.

8.

Integrating quantitative morphological and intratumoural textural characteristics in FDG-PET for the prediction of prognosis in pharynx squamous cell carcinoma patients.

Fujima N, Hirata K, Shiga T, Li R, Yasuda K, Onimaru R, Tsuchiya K, Kano S, Mizumachi T, Homma A, Kudo K, Shirato H.

Clin Radiol. 2018 Dec;73(12):1059.e1-1059.e8. doi: 10.1016/j.crad.2018.08.011. Epub 2018 Sep 21.

PMID:
30245069
9.

Intra-arterial Chemoradiation Therapy as an Option for Maxillary Sinus Cancers.

Homma A, Onimaru R.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):763. doi: 10.1016/j.ijrobp.2018.03.051. Epub 2018 Jun 20. No abstract available.

PMID:
29976485
10.

Present clinical practices of stereotactic irradiation for metastatic brain tumors in Japan: results of questionnaire survey of the Japanese Radiation Oncology Study Group (JROSG) working subgroup for neurological tumors.

Harada K, Igaki H, Abe E, Ariga T, Hayashi N, Kanemoto A, Komiyama T, Matsumoto Y, Nakano T, Onimaru R, Saito H, Sumi M, Tago M, Tanaka K, Maebayashi K, Aoyama H; Japanese Radiation Oncology Study Group (JROSG) Working Subgroup for Neurological Tumors.

Int J Clin Oncol. 2018 Dec;23(6):1015-1022. doi: 10.1007/s10147-018-1313-4. Epub 2018 Jul 3.

PMID:
29971621
11.

Prospective study to evaluate the safety of the world-first spot-scanning dedicated, small 360-degree gantry, synchrotron-based proton beam therapy system.

Nishioka K, Prayongrat A, Ono K, Onodera S, Hashimoto T, Katoh N, Inoue T, Kinoshita R, Yasuda K, Mori T, Onimaru R, Shirato H, Shimizu S.

J Radiat Res. 2018 Mar 1;59(suppl_1):i63-i71. doi: 10.1093/jrr/rrx083.

12.

Dose-finding and efficacy confirmation trial of the superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for locally advanced maxillary sinus cancer (Japan Clinical Oncology Group 1212): Dose-finding phase.

Homma A, Onimaru R, Matsuura K, Shinomiya H, Sakashita T, Shiga K, Tachibana H, Nakamura K, Mizusawa J, Kitahara H, Eba J, Fukuda H, Fujii M, Hayashi R.

Head Neck. 2018 Mar;40(3):475-484. doi: 10.1002/hed.25001. Epub 2017 Nov 11.

13.

Local relapse of nasopharyngeal cancer and Voxel-based analysis of FMISO uptake using PET with semiconductor detectors.

Nishikawa Y, Yasuda K, Okamoto S, Ito YM, Onimaru R, Shiga T, Tsuchiya K, Watanabe S, Takeuchi W, Kuge Y, Peng H, Tamaki N, Shirato H.

Radiat Oncol. 2017 Sep 6;12(1):148. doi: 10.1186/s13014-017-0886-9.

14.

Analysis of inter- and intra fractional partial bladder wall movement using implanted fiducial markers.

Nishioka K, Shimizu S, Shinohara N, Ito YM, Abe T, Maruyama S, Katoh N, Kinoshita R, Hashimoto T, Miyamoto N, Onimaru R, Shirato H.

Radiat Oncol. 2017 Mar 1;12(1):44. doi: 10.1186/s13014-017-0778-z.

15.

Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system.

Katoh N, Soda I, Tamamura H, Takahashi S, Uchinami Y, Ishiyama H, Ota K, Inoue T, Onimaru R, Shibuya K, Hayakawa K, Shirato H.

Radiat Oncol. 2017 Jan 5;12(1):3. doi: 10.1186/s13014-016-0742-3.

16.

Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702): Results for the group with PTV⩾100cc.

Onimaru R, Onishi H, Shibata T, Hiraoka M, Ishikura S, Karasawa K, Matsuo Y, Kokubo M, Shioyama Y, Matsushita H, Ito Y, Shirato H.

Radiother Oncol. 2017 Feb;122(2):281-285. doi: 10.1016/j.radonc.2016.11.022. Epub 2016 Dec 16.

17.

A Retrospective Study of G-Tube Use in Japanese Patients Treated with Concurrent Chemoradiotherapy for Hypopharyngeal Cancer.

Homma A, Hatakeyama H, Mizumachi T, Kano S, Sakashita T, Kuramoto R, Nakamaru Y, Onimaru R, Tsuchiya K, Yoshida D, Yasuda K, Shirato H, Fukuda S.

PLoS One. 2016 Aug 24;11(8):e0161734. doi: 10.1371/journal.pone.0161734. eCollection 2016.

18.

The reoxygenation of hypoxia and the reduction of glucose metabolism in head and neck cancer by fractionated radiotherapy with intensity-modulated radiation therapy.

Okamoto S, Shiga T, Yasuda K, Watanabe S, Hirata K, Nishijima KI, Magota K, Kasai K, Onimaru R, Tuchiya K, Kuge Y, Shirato H, Tamaki N.

Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2147-2154. Epub 2016 Jun 1.

PMID:
27251644
19.

Evaluation of the motion of lung tumors during stereotactic body radiation therapy (SBRT) with four-dimensional computed tomography (4DCT) using real-time tumor-tracking radiotherapy system (RTRT).

Harada K, Katoh N, Suzuki R, Ito YM, Shimizu S, Onimaru R, Inoue T, Miyamoto N, Shirato H.

Phys Med. 2016 Feb;32(2):305-11. doi: 10.1016/j.ejmp.2015.10.093. Epub 2016 Mar 2.

20.

Effectiveness of superselective intra-arterial chemoradiotherapy targeting retropharyngeal lymph node metastasis.

Suzuki T, Sakashita T, Homma A, Hatakeyama H, Kano S, Mizumachi T, Yoshida D, Fujima N, Onimaru R, Tsuchiya K, Yasuda K, Shirato H, Suzuki F, Fukuda S.

Eur Arch Otorhinolaryngol. 2016 Oct;273(10):3331-6. doi: 10.1007/s00405-016-3933-5. Epub 2016 Feb 13.

21.

Intrafractional Baseline Shift or Drift of Lung Tumor Motion During Gated Radiation Therapy With a Real-Time Tumor-Tracking System.

Takao S, Miyamoto N, Matsuura T, Onimaru R, Katoh N, Inoue T, Sutherland KL, Suzuki R, Shirato H, Shimizu S.

Int J Radiat Oncol Biol Phys. 2016 Jan 1;94(1):172-180. doi: 10.1016/j.ijrobp.2015.09.024. Epub 2015 Sep 25.

PMID:
26700711
22.

Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403.

Nagata Y, Hiraoka M, Shibata T, Onishi H, Kokubo M, Karasawa K, Shioyama Y, Onimaru R, Kozuka T, Kunieda E, Saito T, Nakagawa K, Hareyama M, Takai Y, Hayakawa K, Mitsuhashi N, Ishikura S.

Int J Radiat Oncol Biol Phys. 2015 Dec 1;93(5):989-96. doi: 10.1016/j.ijrobp.2015.07.2278. Epub 2015 Nov 11.

PMID:
26581137
23.

Three-dimensional conformal fractionated radiotherapy for spinal schwannoma with a paravertebral or an intraosseous component.

Onimaru R, Hida K, Takeda N, Onodera S, Nishikawa Y, Mori T, Shirato H.

Jpn J Radiol. 2015 Dec;33(12):757-63. doi: 10.1007/s11604-015-0492-4. Epub 2015 Oct 27.

24.

Intra-arterial chemoradiotherapy for head and neck cancer.

Homma A, Onimaru R, Matsuura K, Robbins KT, Fujii M.

Jpn J Clin Oncol. 2016 Jan;46(1):4-12. doi: 10.1093/jjco/hyv151. Epub 2015 Oct 20. Review.

PMID:
26486825
25.

Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer with PTV<100 cc using a continual reassessment method (JCOG0702).

Onimaru R, Shirato H, Shibata T, Hiraoka M, Ishikura S, Karasawa K, Matsuo Y, Kokubo M, Shioyama Y, Matsushita H, Ito Y, Onishi H.

Radiother Oncol. 2015 Aug;116(2):276-80. doi: 10.1016/j.radonc.2015.07.008. Epub 2015 Jul 29.

26.

Indications for superselective intra-arterial cisplatin infusion and concomitant radiotherapy in cases of hypopharyngeal cancer.

Furusawa J, Homma A, Onimaru R, Sakashita T, Yoshida D, Hatakeyama H, Mizumachi T, Kano S, Tsuchiya K, Yasuda K, Shirato H, Fukuda S.

Auris Nasus Larynx. 2015 Dec;42(6):443-8. doi: 10.1016/j.anl.2015.04.003. Epub 2015 Apr 28.

27.

The efficacy of superselective intra-arterial infusion with concomitant radiotherapy for adenoid cystic carcinoma of the head and neck.

Homma A, Sakashita T, Hatakeyama H, Kano S, Mizumachi T, Nakamaru Y, Yoshida D, Onimaru R, Tsuchiya K, Yasuda K, Shirato H, Fukuda S.

Acta Otolaryngol. 2015 Sep;135(9):950-4. doi: 10.3109/00016489.2015.1040171. Epub 2015 Apr 30.

PMID:
25925195
28.

Olfactory neuroblastoma: the long-term outcome and late toxicity of multimodal therapy including radiotherapy based on treatment planning using computed tomography.

Mori T, Onimaru R, Onodera S, Tsuchiya K, Yasuda K, Hatakeyama H, Kobayashi H, Terasaka S, Homma A, Shirato H.

Radiat Oncol. 2015 Apr 15;10:88. doi: 10.1186/s13014-015-0397-5.

29.

Comparison of acute toxicities associated with cetuximab-based bioradiotherapy and platinum-based chemoradiotherapy for head and neck squamous cell carcinomas: A single-institution retrospective study in Japan.

Sakashita T, Homma A, Hatakeyama H, Furusawa J, Kano S, Mizumachi T, Iizuka S, Onimaru R, Tsuchiya K, Yasuda K, Shirato H, Fukuda S.

Acta Otolaryngol. 2015 Aug;135(8):853-8. doi: 10.3109/00016489.2015.1030772. Epub 2015 Mar 26.

PMID:
25814008
30.

Clinical outcomes of weekly cisplatin chemoradiotherapy for patients with pyriform sinus cancer.

Sakashita T, Homma A, Hatakeyama H, Furusawa J, Kano S, Mizumachi T, Iizuka S, Onimaru R, Tsuchiya K, Yasuda K, Shirato H, Fukuda S.

Int J Clin Oncol. 2015 Dec;20(6):1081-5. doi: 10.1007/s10147-015-0821-8. Epub 2015 Mar 25.

31.

Management for squamous cell carcinoma of the nasal cavity and ethmoid sinus: A single institution experience.

Homma A, Nakamaru Y, Sakashita T, Onimaru R, Terasaka S, Tsuchiya K, Yoshida D, Yasuda K, Hatakeyama H, Furusawa J, Mizumachi T, Kano S, Shirato H, Fukuda S.

Auris Nasus Larynx. 2015 Oct;42(5):377-81. doi: 10.1016/j.anl.2015.02.005. Epub 2015 Mar 3.

32.

Combined use of 18 F-FDG PET and corticosteroid for diagnosis of deep-seated primary central nervous system lymphoma without histopathological confirmation.

Yamaguchi S, Hirata K, Kaneko S, Kobayashi H, Shiga T, Kobayashi K, Onimaru R, Shirato H, Tamaki N, Terasaka S, Houkin K.

Acta Neurochir (Wien). 2015 Feb;157(2):187-94. doi: 10.1007/s00701-014-2290-7. Epub 2014 Dec 10.

PMID:
25488176
33.

Dose-finding and efficacy confirmation trial of superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for patients with locally advanced maxillary sinus cancer (JCOG1212, RADPLAT-MSC).

Homma A, Nakamura K, Matsuura K, Mizusawa J, Onimaru R, Fukuda H, Fujii M.

Jpn J Clin Oncol. 2015 Jan;45(1):119-22. doi: 10.1093/jjco/hyu169. Epub 2014 Oct 19.

34.

Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with concurrent weekly cisplatin chemoradiotherapy for locally advanced head and neck squamous cell carcinoma.

Mizumachi T, Homma A, Kakizaki T, Sakashita T, Kano S, Hatakeyama H, Tsuchiya K, Yasuda K, Onimaru R, Shirato H, Taguchi J, Shimizu Y, Kinoshita I, Akita H, Fukuda S.

Int J Clin Oncol. 2015 Jun;20(3):431-7. doi: 10.1007/s10147-014-0726-y. Epub 2014 Jul 5.

35.

Early results of urethral dose reduction and small safety margin in intensity-modulated radiation therapy (IMRT) for localized prostate cancer using a real-time tumor-tracking radiotherapy (RTRT) system.

Shimizu S, Nishioka K, Suzuki R, Shinohara N, Maruyama S, Abe T, Kinoshita R, Katoh N, Onimaru R, Shirato H.

Radiat Oncol. 2014 May 21;9:118. doi: 10.1186/1748-717X-9-118.

36.

Prognostic factors for survival in patients with high-grade meningioma and recurrence-risk stratification for application of radiotherapy.

Yamaguchi S, Terasaka S, Kobayashi H, Asaoka K, Motegi H, Nishihara H, Kanno H, Onimaru R, Ito YM, Shirato H, Houkin K.

PLoS One. 2014 May 12;9(5):e97108. doi: 10.1371/journal.pone.0097108. eCollection 2014.

37.

Influence of respiration on dose calculation in stereotactic body radiotherapy of the lung.

Yamazaki R, Onimaru R, Katoh N, Inoue T, Nishioka T, Shirato H, Date H.

Radiol Phys Technol. 2014 Jul;7(2):284-9. doi: 10.1007/s12194-014-0263-4. Epub 2014 Mar 19.

PMID:
24643842
38.

Salvage operations for patients with persistent or recurrent cancer of the maxillary sinus after superselective intra-arterial infusion of cisplatin with concurrent radiotherapy.

Sakashita T, Homma A, Hatakeyama H, Kano S, Mizumachi T, Furusawa J, Yoshida D, Fujima N, Onimaru R, Tsuchiya K, Yasuda K, Shirato H, Suzuki F, Fukuda S.

Br J Oral Maxillofac Surg. 2014 Apr;52(4):323-8. doi: 10.1016/j.bjoms.2014.01.018. Epub 2014 Feb 26.

39.
40.

Prospective phase II study of image-guided local boost using a real-time tumor-tracking radiotherapy (RTRT) system for locally advanced bladder cancer.

Nishioka K, Shimizu S, Shinohara N, Ito YM, Abe T, Maruyama S, Kinoshita R, Harada K, Nishikawa N, Miyamoto N, Onimaru R, Shirato H.

Jpn J Clin Oncol. 2014 Jan;44(1):28-35. doi: 10.1093/jjco/hyt182. Epub 2013 Dec 2.

41.

The incidence of late neck recurrence in N0 maxillary sinus squamous cell carcinomas after superselective intra-arterial chemoradiotherapy without prophylactic neck irradiation.

Sakashita T, Homma A, Hatakeyama H, Kano S, Mizumachi T, Furusawa J, Yoshida D, Fujima N, Onimaru R, Tsuchiya K, Yasuda K, Shirato H, Fukuda S.

Eur Arch Otorhinolaryngol. 2014 Oct;271(10):2767-70. doi: 10.1007/s00405-013-2806-4. Epub 2013 Nov 9.

42.

Superselective intra-arterial cisplatin infusion and concomitant radiotherapy for maxillary sinus cancer.

Homma A, Sakashita T, Yoshida D, Onimaru R, Tsuchiya K, Suzuki F, Yasuda K, Hatakeyama H, Furusawa J, Mizumachi T, Kano S, Inamura N, Taki S, Shirato H, Fukuda S.

Br J Cancer. 2013 Dec 10;109(12):2980-6. doi: 10.1038/bjc.2013.663. Epub 2013 Nov 5.

43.

Evaluation of inter-observer variability of bladder boundary delineation on cone-beam CT.

Nishioka K, Shimizu S, Kinoshita R, Inoue T, Onodera S, Yasuda K, Harada K, Nishikawa Y, Onimaru R, Shirato H.

Radiat Oncol. 2013 Jul 23;8:185. doi: 10.1186/1748-717X-8-185.

44.

Stereotactic body radiotherapy using gated radiotherapy with real-time tumor-tracking for stage I non-small cell lung cancer.

Inoue T, Katoh N, Onimaru R, Shimizu S, Tsuchiya K, Suzuki R, Sakakibara-Konishi J, Shinagawa N, Oizumi S, Shirato H.

Radiat Oncol. 2013 Mar 21;8:69. doi: 10.1186/1748-717X-8-69.

45.

What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy.

Toramatsu C, Katoh N, Shimizu S, Nihongi H, Matsuura T, Takao S, Miyamoto N, Suzuki R, Sutherland K, Kinoshita R, Onimaru R, Ishikawa M, Umegaki K, Shirato H.

Radiat Oncol. 2013 Mar 5;8:48. doi: 10.1186/1748-717X-8-48.

46.

Graphical representation of the effects on tumor and OAR for determining the appropriate fractionation regimen in radiation therapy planning.

Mizuta M, Date H, Takao S, Kishimoto N, Sutherland KL, Onimaru R, Shirato H.

Med Phys. 2012 Nov;39(11):6791-5. doi: 10.1118/1.4757580.

47.

Regional control after concomitant chemoradiotherapy without planned neck dissection in node-positive head and neck squamous cell carcinomas.

Sakashita T, Homma A, Oridate N, Suzuki S, Hatakeyama H, Kano S, Mizumachi T, Onimaru R, Tsuchiya K, Yasuda K, Shirato H, Fukuda S.

Auris Nasus Larynx. 2013 Apr;40(2):211-5. doi: 10.1016/j.anl.2012.07.002. Epub 2012 Aug 4.

48.

Clinical outcomes of stereotactic body radiotherapy for patients with lung tumors in the state of oligo-recurrence.

Inoue T, Katoh N, Onimaru R, Shirato H.

Pulm Med. 2012;2012:369820. doi: 10.1155/2012/369820. Epub 2012 Jul 11.

49.

Symptomatic outcomes in relation to tumor expansion after fractionated stereotactic radiation therapy for vestibular schwannomas: single-institutional long-term experience.

Aoyama H, Onodera S, Takeichi N, Onimaru R, Terasaka S, Sawamura Y, Shirato H.

Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):329-34. doi: 10.1016/j.ijrobp.2012.05.003. Epub 2012 Jun 15.

PMID:
22704983
50.

SU-E-J-42: Motion Adaptive Image Filter for Low Dose X-Ray Fluoroscopy in the Real-Time Tumor-Tracking Radiotherapy System.

Miyamoto N, Ishikawa M, Sutherland K, Suzuki R, Matsuura T, Takao S, Toramatsu C, Nihongi H, Shimizu S, Onimaru R, Umegaki K, Shirato H.

Med Phys. 2012 Jun;39(6Part6):3661-3662. doi: 10.1118/1.4734877.

PMID:
28517566

Supplemental Content

Loading ...
Support Center